Literature DB >> 6626765

Cardiorespiratory adjustments in chronic sickle cell anemia.

J Lonsdorfer, P Bogui, A Otayeck, E Bursaux, C Poyart, R Cabannes.   

Abstract

During the intercrisis periods, patients homozygous for sickle cell anemia (SS) show clinical symptoms of severe impairment of oxygen transport mechanisms. We have determined respiratory lung function tests, arterial and venous blood gases and cardiocirculatory parameters in 39 SS patients (mean age 22 +/- 5 yr) at distance from any vaso-occlusive crisis or blood transfusion. The patient group was compared to subjects homozygous for HbA (AA) of the same ethnic origin. Determinations were made at rest and after a 5 min mild exercise period. The main alterations in oxygen transport parameters observed in SS patients were: 1) a moderate reduction in vital capacity and maximal ventilation (pure restrictive syndrome), 2) an arterial hypoxemia which worsened the already low oxygen content of blood due to anemia, and 3) a low arterio-venous oxygen saturation difference which is very surprising in anemic patients. The normal oxygen consumption rate was thus insured by a 70% increase of the cardiac output at rest. A particular abnormality found in SS patients was the high Po2 in mixed venous blood. The decreased affinity of blood for oxygen resulting from the polymerization of HbS in the erythrocytes led to an almost normal venous blood unsaturation and thus a decreased release of oxygen from this anemic blood. These results indicate that peripheral blood flow was permanently increased in SS patients. This may be in part at the origin of the arterial hypoxemia induced by an increased pulmonary blood shunting. Sickle cell anemia is more severe than other anemias of comparable intensity as, due to the sickling process, these patients appear to be at the upper limit of physiological compensatory mechanisms usually encountered in chronic anemia.

Entities:  

Mesh:

Year:  1983        PMID: 6626765

Source DB:  PubMed          Journal:  Bull Eur Physiopathol Respir        ISSN: 0395-3890


  16 in total

1.  Can we just say NO to sickle cell anemia?

Authors:  R L Nagel
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  Arterialization of peripheral venous blood in sickle cell disease.

Authors:  Masoud Nahavandi; Richard M Millis; Fatemeh Tavakkoli; Meville Q Wyche; Elliott Perlin; William P Winter; Oswaldo Castro
Journal:  J Natl Med Assoc       Date:  2002-05       Impact factor: 1.798

3.  Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications.

Authors:  Jonathan C Goldsmith; Vence L Bonham; Clinton H Joiner; Gregory J Kato; Allan S Noonan; Martin H Steinberg
Journal:  Am J Hematol       Date:  2012-02-03       Impact factor: 10.047

4.  Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.

Authors:  Dhananjay K Kaul; Xiao-du Liu; Hee-Yoon Chang; Ronald L Nagel; Mary E Fabry
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

5.  Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results.

Authors:  W H Waugh; C W Daeschner; B A Files; M E McConnell; S E Strandjord
Journal:  J Natl Med Assoc       Date:  2001-10       Impact factor: 1.798

6.  Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.

Authors:  Dhananjay K Kaul; Xiaoqin Zhang; Trisha Dasgupta; Mary E Fabry
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

7.  Pulmonary Function Tests in Sickle Cell Disease.

Authors:  Raviraj Purohit; Sanjeev S Rao; Jagdish P Goyal; Vijay B Shah; Jaykaran Charan
Journal:  Indian J Pediatr       Date:  2016-03-05       Impact factor: 1.967

8.  Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1α expression in normoxic sickle mice: microvascular implications.

Authors:  Dhananjay K Kaul; Mary E Fabry; Sandra M Suzuka; Xiaoqin Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-02       Impact factor: 4.733

Review 9.  The polymerization of sickle hemoglobin in solutions and cells.

Authors:  F A Ferrone
Journal:  Experientia       Date:  1993-02-15

Review 10.  Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.

Authors:  Roberto F Machado; Harrison W Farber
Journal:  Clin Chest Med       Date:  2013-10-17       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.